PACTR201411000937373招募中未知
A trial of the safety of low dose primaquine in addition to ACTs commonly used in Senegal.
niversity Cheikh Anta DIOP of Dakar, Department of Medical Parasitology.0 个研究点目标入组 300 人开始时间: 2014年11月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Year(s) 至 50 Year(s)（—）
- 性别
- All
入选标准
- •1. Adult patients with acute uncomplicated P. falciparum malaria;
- •2. P. falciparum monospecific infection with parasite density ranged from 1000 to 100 000 trophozoite/¿L.
- •3. Willingness to participate in the planed study investigations and to remain in the study area for the duration of the study;
- •4. Participants informed consent;
- •5. Absence of known chronic illness such as hypertension, diabetes, renal and liver disease.
排除标准
- •1. Known allergy to the study medications;
- •2. Presence of severe anaemia (haemoglobin < 8 g/dl) at enrolment;
- •3. Pregnancy, or breastfeeding.
研究者
相似试验
已完成
3 期
Monitoring safety of single-low dose primaquine co-administered with ALu in routine healthcare practice: addressing potential implementation challenges and policy options for effective roll outMalariaPACTR202007653561223Ifakara Health Institute600
已完成
4 期
Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of GametocytesPlasmodium FalciparumNCT02090036Muhimbili University of Health and Allied Sciences220
已完成
3 期
Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in UgandaFalciparum MalariaNCT01365598London School of Hygiene and Tropical Medicine468
尚未招募
4 期
Effect of Primaquine in the patients of P.vivax and P.falciparum malaria.CTRI/2010/091/001040il50
招募中
不适用
Pilot study on the efficacy and safty of low-dose tocilizumab therapy in elderly RA patientsRheumatoid arthritisJPRN-UMIN000008185Kyushu University Beppu Hospital Department of Metabolism, Hematology and Rheumatic Diseases (DMHRDs)10